MedPath
TGA Approval

CABAZITAXEL-DRLA cabazitaxel 60 mg/1.5 mL concentrated injection vial (287927)

287927

CABAZITAXEL-DRLA cabazitaxel 60 mg/1.5 mL concentrated injection vial

Dr Reddys Laboratories Australia Pty Ltd

July 23, 2018

Medicine

Medicine

Active

Registered

Active Ingredients

cabazitaxel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CABAZITAXEL-DRLA cabazitaxel 60 mg/1.5 mL concentrated injection vial (287927) - TGA 批准文号 | MedPath